Global Regenerative Medicine Market by Technology

Global Regenerative Medicine Market by Technology (Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics), By Source (Autologous and Allogenic), By Application (Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others), By End-Users(Hospitals, Ambulatory surgery centers (ASCs), Clinics and Others), and By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)

Global Regenerative Medicine Market Overview:

Regenerative medicine refers to the use of biological and engineering theoretical methods to create lost or functionally damaged tissues and organs. Regenerative medicine can be described as the theory, technology, and surgical operations of tissue regeneration in the body. It can also consider as a discipline that studies how to promote the physiological repair of trauma and tissue and organ defects and how to perform tissue and organ regeneration and functional reconstruction.

Regenerative medicine marks a new era for the medicine to rebuild, regenerate, manufacture, and replace tissues and organs. It also brings new hope for most medical problems facing humans, such as cardiovascular disease, autoimmune diseases, diabetes, Malignant tumors, Alzheimer’s disease, Parkinson’s disease, congenital genetic defects, and other diseases and the treatment of various tissue and organ damage.

Global Regenerative Medicine Market Insights

Global Regenerative Medicine Market expected to grow with a CAGR 19.14% during the estimated period, 2019-2027 and projected to generate revenue of USD 190.08 Billion by 2027. The rise in the prevalence of chronic diseases & trauma emergencies and the emergence of stem cell technology is likely to boom the global regenerative medicine market in the forecast period. Additionally, conditions related to aging has become a significant medical and social problem across the globe, which leads to the growth of the global regenerative medicine market. Moreover, the rise in the number of patients with cardiovascular disease, diabetes, and millions of patients with Alzheimer’s disease and hematological tumors will accelerate the global regenerative medicine market.

Furthermore, accelerating the development of the regenerative medicine market is of great and practical significance for improving human living standards and benefiting human health. Further, the surge in funding for regenerative medicine research, and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds are vital factors projected to trigger the global regenerative medicine market.

Growth Driver

The rise in diseases related to aging and chronic diseases

The increase in diseases related to aging has become a significant medical and social problem.  At present, one of the primary causes among the elderly population is cell aging, which leads to issues such as cell damage, the development of inflammatory processes, slow regeneration, and reduced functional activity of corresponding tissues and organs. According to WHO, the proportion of the burden of non-communicable diseases anticipated to increase to 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity, and diabetes. It has projected that, by 2020, chronic diseases will account for almost three-quarter of all deaths worldwide, and that 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries.

Rising Government Investments in Regenerative Medicine

Governments and people in various countries have actively invested considerable resources in recent years to develop regenerative medicine. In the Asia Pacific, Japan is the first country to propose specific legislation of the global regenerative medicine. Clinical trials would also begin in areas such as the retina, the esophagus, heart, etc. World Health Organization (WHO) launched an initiative to eliminate hepatitis by 2030.

Resolving past incurable diseases with the help of human tissue or organ regeneration

Regenerative medicine aimed at repairing, replacing, and rejuvenating tissues or organs to improve human life caused by trauma, disease, or natural aging. It combines different specialties across fields, including biology, chemistry, computer science, genetics, robotics, etc., not only to activate the body’s original natural repair mechanism, but also to make it doubly useful. According to the World Bank, the population aged 65 and above increased from 7.64% in 2010 to 8.92% of the overall population in 2018.

Technology Segmental Analysis

Based on technology, the global Regenerative Medicine Market categorized into Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics. The Cellular Therapy segment projected to lead the market and witnessed to exhibit 48.53% market share in 2018, owing to its efficiency in restoring the lost function of tissues and organs. Cellular Therapy can solve the problem of organ transplantation, and organ transplantation can become one of the means of cancer treatment.  The gene therapy segment will drive by its application to reduce levels of the disease-causing version of a protein and increase the production of disease-fighting proteins.

Source Segmental Analysis

Based on the Source, the Global Regenerative Medicine Market bifurcated into Autologous and Allogenic. The Autologous segment estimated to exhibit 61.14% market share in 2018 and anticipated to dominate the market due to their features such as cells derived from patients themselves. The use of autologous is a safe therapeutic option as the cells will not elicit an immune response. Allogenic will grow by its properties, such as the stem cells are from a donor. Allogenic do not elicit robust immune responses.

Application Segmental Analysis

Based on the application, the Global Regenerative Medicine Market segmented into Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others. The oncology segment witnessed to exhibit 43.47% market share in 2018 and expected to dominate the market due to the surge in the cancer-affected population along with huge investments done in research related to cancer and development of regenerative & advanced cell therapies by the various government in developing and developed countries.

The dermatology segment will driven by the presence of easy grafting techniques for dermatological wounds and diseases related to skin.

End-User Segmental Analysis

By the End-user, the Global Regenerative Medicine market segregated into Hospitals, Ambulatory surgery centers (ASCs), Clinics, and Others. The Hospital segment generated the highest revenue with 52.46% market share in 2018 and anticipated to dominate the market over the forecast period due to the partnership formed between hospitals and regenerative medicine manufacturing companies to provide cell therapy and tissue scaffolds to improve patient care and treatment. The clinics’ segment will grow on account of certified clinics that offer healthcare services to people. These centers have specialized departments for regenerative medicine, which provide care and treatment.

Region Segmental Analysis

Based on geography, the global Regenerative Medicine market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America attributed to generating 41.68% market share in 2018 and estimated to generate USD 66.57 Billion revenue by 2027 owing to the availability of advanced technologies and the presence of research institutes and the rising initiatives by government and private organizations. Europe will be the fastest-growing region with a CAGR of 19.33% during the forecast period. It has generated revenue of 64.32 USD Billion in 2017 on account of the enormous growing aging population along with rising medical needs of the people and changing lifestyle.

Competitor Analysis

Companies such as Integra LifeSciences Corporation, MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic Plc., Athersys Inc., US Stem Cell, Organogenesis Inc., Acelity Holdings Inc., Isto Biologics, Cryolife Inc. and Baxter are the key players in the Global Regenerative Medicine Market.

Key Stakeholders

  • Market research and consulting firms
  • Industry associations
  • Global Regenerative Medicine Service Providers
  • Research organizations and consulting companies
  • Organizations, associations, and alliances related to Regenerative Medicine
  • Regulatory bodies

The objective of the Research

  • Market Modelling Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
  • Product Analysis Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
  • Market Trend and Economic Factors Analysis This analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
  • Market Segmental Analysis Segmental analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
  • Geographical Mapping The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.

Market Modelling

By Technology

  • Cellular Therapy
  • Gene Therapy
  • Tissue Engineering
  • Exosome Therapeutics

By Source

  • Autologous
  • Allogenic

By Application

  • Dermatology
  • Musculoskeletal
  • Oncology
  • Cardiovascular
  • Neurology
  • Hematology & Immunology
  • Others

By End-Users

  • Hospitals
  • Ambulatory surgery centers (ASCs)
  • Clinics
  • Others

 By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Global Regenerative Medicine Market

Report Content

  1. Research Strategic Development
    • Market Modelling
    • Product Analysis
    • Market Trend and Economic Factors Analysis
    • Market Segmental Analysis
    • Geographical Mapping
    • Country Wise Segregation
  2. Research Methodology
    • Identification of Target Market
    • Data Acquisition
    • Refining of Data/ Data Transformations
    • Data Validation through Primary Techniques
    • Exploratory Data Analysis
    • Graphical Techniques/Analysis
    • Quantitative Techniques/Analysis
    • Visual Result/Presentation
  3. Executive Summary
  4. Market Insights
    • Supply Chain Analysis
    • Economic Factor Analysis
      • Drivers
      • Trends
      • Opportunities
      • Challenges
    • Technological Landscape
    • Competitors & Product Analysis
    • Policy & Regulatory Framework
    • Company market share analysis, 2018
    • Porter’s Five forces analysis
    • New Investment Analysis
    • PESTEL Analysis
  5. Global Regenerative Medicine Market Overview
    • Market Size & Forecast, 2016-2027
      • Global Regenerative Medicine Market By Value (USD)
    • Market Share & Forecast, 2016-2027
      • By Technology
        • Cellular Therapy
        • Gene Therapy
        • Tissue Engineering
        • Exosome Therapeutics
      • By Source
        • Autologous
        • Allogenic
      • By Application
        • Dermatology
        • Musculoskeletal
        • Oncology
        • Cardiovascular
        • Neurology
        • Hematology & Immunology
        • Others
      • By End-Users
        • Hospitals
        • Ambulatory surgery centers (ASCs)
        • Clinics
        • Others
      • By Region
        • North America
        • Europe
        • Asia Pacific
        • South America
        • Middle East & Africa
  1. North America Regenerative Medicine Market
    • North America Regenerative Medicine Market Size & Forecast, 2016-2027
      • By Value (USD)
    • North America Regenerative Medicine Market Estimates & Forecast, 2016-2027 (USD Million)
      • By Technology
        • Cellular Therapy
        • Gene Therapy
        • Tissue Engineering
        • Exosome Therapeutics
      • By Source
        • Autologous
        • Allogenic
      • By Application
        • Dermatology
        • Musculoskeletal
        • Oncology
        • Cardiovascular
        • Neurology
        • Hematology & Immunology
        • Others
      • By End-Users
        • Hospitals
        • Ambulatory surgery centers (ASCs)
        • Clinics
        • Others
      • By Country
        • S.A
        • Canada
        • Mexico
      • Company Market Share (Top 3-5)
      • Economic Impact Study on North America Regenerative Medicine Market
  1. Europe Regenerative Medicine Market
    • Europe Regenerative Medicine Market Size & Forecast, 2016-2027
      • By Value (USD)
    • Europe Regenerative Medicine Market Estimates & Forecast, 2016-2027 (USD Million)
      • By Technology
        • Cellular Therapy
        • Gene Therapy
        • Tissue Engineering
        • Exosome Therapeutics
      • By Source
        • Autologous
        • Allogenic
      • By Application
        • Dermatology
        • Musculoskeletal
        • Oncology
        • Cardiovascular
        • Neurology
        • Hematology & Immunology
        • Others
      • By End-Users
        • Hospitals
        • Ambulatory surgery centers (ASCs)
        • Clinics
        • Others
      • By Country
        • Germany
        • K
        • France
        • Italy
        • Netherlands
        • Rest of Europe
      • Company Market Share (Top 3-5)
      • Economic Impact Study on Europe Regenerative Medicine Market
  1. Asia Pacific Regenerative Medicine Market
    • Asia Pacific Regenerative Medicine Market Size & Forecast,2016-2027
      • By Value (USD)
    • Asia Pacific Regenerative Medicine Market Estimates & Forecast, 2016-2027 (USD Million)
      • By Technology
        • Cellular Therapy
        • Gene Therapy
        • Tissue Engineering
        • Exosome Therapeutics
      • By Source
        • Autologous
        • Allogenic
      • By Application
        • Dermatology
        • Musculoskeletal
        • Oncology
        • Cardiovascular
        • Neurology
        • Hematology & Immunology
        • Others
      • By End-Users
        • Hospitals
        • Ambulatory surgery centers (ASCs)
        • Clinics
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • Rest of Asia Pacific
      • Company Market Share (Top 3-5)
      • Economic Impact Study on Asia Pacific Regenerative Medicine Market
  1. South America Regenerative Medicine Market
    • South America Regenerative Medicine Market Size & Forecast, 2016-2027
      • By Value (USD)
    • South America Regenerative Medicine Market estimates & forecast, 2016-2027 (USD Million)
      • By Technology
        • Cellular Therapy
        • Gene Therapy
        • Tissue Engineering
        • Exosome Therapeutics
      • By Source
        • Autologous
        • Allogenic
      • By Application
        • Dermatology
        • Musculoskeletal
        • Oncology
        • Cardiovascular
        • Neurology
        • Hematology & Immunology
        • Others
      • By End-Users
        • Hospitals
        • Ambulatory surgery centers (ASCs)
        • Clinics
        • Others
      • By Country
        • Brazil
        • Argentina
        • Rest of South America
      • Company Market Share (Top 3-5)
      • Economic Impact Study on South America Regenerative Medicine Market
  1. Middle East & Africa Regenerative Medicine Market
    • Middle East & Africa Market Size & Forecast, 2016-2027
      • By Value (USD)
    • Middle East & Africa Market estimates & forecast, 2016-2027 (USD Million)
      • By Technology
        • Cellular Therapy
        • Gene Therapy
        • Tissue Engineering
        • Exosome Therapeutics
      • By Source
        • Autologous
        • Allogenic
      • By Application
        • Dermatology
        • Musculoskeletal
        • Oncology
        • Cardiovascular
        • Neurology
        • Hematology & Immunology
        • Others
      • By End-Users
        • Hospitals
        • Ambulatory surgery centers (ASCs)
        • Clinics
        • Others
      • By Country
        • Saudi Arabia
        • UAE
        • South Africa
        • Rest of Middle East & Africa
      • Company Market Share (Top 3-5)
      • Economic Impact Study on Middle East & Africa Regenerative Medicine Market
  1. Competitor Analysis
    • Company Description
    • Financial Analysis
    • Key Products
    • Key Management Personnel
    • Contact Address
    • SWOT Analysis
    • Company Profiles
      • Integra LifeSciences Corporation
      • MiMedx Group, Inc.
      • AstraZeneca
      • Hoffmann-La Roche Ltd
      • Merck & Co., Inc.
      • Pfizer Inc.
      • Stryker Corporation
      • Zimmer Biomet Holdings Inc.
      • Medtronic Plc.
      • Athersys Inc.
      • US Stem Cell
      • Organogenesis Inc.
      • Acelity Holdings Inc.
      • Isto Biologics
      • Cryolife Inc.
      • Baxter
      • Other Leading Players